Mahitab Kamal

Managing Wound Closure business in Qatar in public and private sector.

Significant Achievements:
- EMEA ELITE Contest award for Plus sutures 2018
- Creating one Ethicon contract in SIDRA medical research center on 2018.
- Best Salesperson of the year for 2017 for Wound Closure Middle east.
- Hamad Medical Corporation conversion to PLUS.
- 111% Total In-Market Sales growth 2014 VS. 2018.
- 488% Growth in In-Market Plus sutures sales 2014 Vs. 2018.
- 60% Plus penetration rate in 2018 VS. 16% in 2014.

Participating in the most important healthcare project in Qatar “The National Health Insurance Scheme”.
- Managing prior authorization requests - System and process support.
- Medical cases coverage. - Handling complaints.
- Manual members enrollment.
- Participate in Dry runs to the new healthcare providers.

Launching Caldolor: The First FDA Ibuprofen I.V injection in the market.
Targeted Specialties: Anesthesiologists, Emergency general practitioners,
Launching Formoline: The Slimming agent number one in Germany.
Targeted Specialties: Pharmacies.

It’s a key link between medical and pharmaceutical companies and healthcare professionals. I work strategically to increase the awareness and use of a company’s pharmaceutical and medical products in settings such as general practices, primary care trusts and hospital.